GUTTMACHER INSTITUTE

- HR 4104- Health Equity and Access under the Law for Immigrant Families Act of 2025- emails to House for cosponsorship - HR 10597, S 5539- Affordability is Access Act, emails to House and Senate for cosponsorship, social media content development and engagement in support of bill re-introduction. -Letter to Senate HELP Committee opposing FDA commissioner nominee Heidi Overton

Client expense: — · Firm income: —

Matched citations: HR 4104

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- met with House offices to cosponsor the bill -Meeting with Rep. Pettersen's office to discuss potential letter to EPA regarding EPA action on mifepristone - Meeting with Senator Merkley's office on potential resolution or oversight letter regarding EPA action on mifepristone - Briefing to Hill staff with asks including opposing H.R.7983 (Clean Water for All Life Act) and appropriations riders related to mifepristone environmental claims - Letter to Senate HELP Committee opposing FDA commissioner nominee Heidi Overton - Worked with Senator Murray's office on oversight letter regarding EPA action on mifepristone - HR 10597, S 5539- Affordability is Access Act, emailed House and Senate offices to get cosponsors on bill - S 5108, HR 9941- Right to IVF Act, endorsed bill - HR 10600, S 5565- Abortion is Healthcare Everywhere Act- Social media content development and engagement in support of bill re-introduction, Met with Rep. Schakowsky and Sen. Booker staff; emails to House and Senate for cosponsorship. - HR 10597, S 5539- Affordability Is Access Act- Social media content development and engagement in support of bill re-introduction, emails to House for cosponsorship

Client expense: — · Firm income: —

Matched citations: H.R. 4611

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- met with House offices to cosponsor the bill -Meeting with Rep. Pettersen's office to discuss potential letter to EPA regarding EPA action on mifepristone - Meeting with Senator Merkley's office on potential resolution or oversight letter regarding EPA action on mifepristone - Briefing to Hill staff with asks including opposing H.R.7983 (Clean Water for All Life Act) and appropriations riders related to mifepristone environmental claims - Letter to Senate HELP Committee opposing FDA commissioner nominee Heidi Overton - Worked with Senator Murray's office on oversight letter regarding EPA action on mifepristone - HR 10597, S 5539- Affordability is Access Act, emailed House and Senate offices to get cosponsors on bill - S 5108, HR 9941- Right to IVF Act, endorsed bill - HR 10600, S 5565- Abortion is Healthcare Everywhere Act- Social media content development and engagement in support of bill re-introduction, Met with Rep. Schakowsky and Sen. Booker staff; emails to House and Senate for cosponsorship. - HR 10597, S 5539- Affordability Is Access Act- Social media content development and engagement in support of bill re-introduction, emails to House for cosponsorship

Client expense: — · Firm income: —

Matched citations: H.R.7983

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- met with House offices to cosponsor the bill -Meeting with Rep. Pettersen's office to discuss potential letter to EPA regarding EPA action on mifepristone - Meeting with Senator Merkley's office on potential resolution or oversight letter regarding EPA action on mifepristone - Briefing to Hill staff with asks including opposing H.R.7983 (Clean Water for All Life Act) and appropriations riders related to mifepristone environmental claims - Letter to Senate HELP Committee opposing FDA commissioner nominee Heidi Overton - Worked with Senator Murray's office on oversight letter regarding EPA action on mifepristone - HR 10597, S 5539- Affordability is Access Act, emailed House and Senate offices to get cosponsors on bill - S 5108, HR 9941- Right to IVF Act, endorsed bill - HR 10600, S 5565- Abortion is Healthcare Everywhere Act- Social media content development and engagement in support of bill re-introduction, Met with Rep. Schakowsky and Sen. Booker staff; emails to House and Senate for cosponsorship. - HR 10597, S 5539- Affordability Is Access Act- Social media content development and engagement in support of bill re-introduction, emails to House for cosponsorship

Client expense: — · Firm income: —

Matched citations: HR 9941

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- met with House offices to cosponsor the bill -Meeting with Rep. Pettersen's office to discuss potential letter to EPA regarding EPA action on mifepristone - Meeting with Senator Merkley's office on potential resolution or oversight letter regarding EPA action on mifepristone - Briefing to Hill staff with asks including opposing H.R.7983 (Clean Water for All Life Act) and appropriations riders related to mifepristone environmental claims - Letter to Senate HELP Committee opposing FDA commissioner nominee Heidi Overton - Worked with Senator Murray's office on oversight letter regarding EPA action on mifepristone - HR 10597, S 5539- Affordability is Access Act, emailed House and Senate offices to get cosponsors on bill - S 5108, HR 9941- Right to IVF Act, endorsed bill - HR 10600, S 5565- Abortion is Healthcare Everywhere Act- Social media content development and engagement in support of bill re-introduction, Met with Rep. Schakowsky and Sen. Booker staff; emails to House and Senate for cosponsorship. - HR 10597, S 5539- Affordability Is Access Act- Social media content development and engagement in support of bill re-introduction, emails to House for cosponsorship

Client expense: — · Firm income: —

Matched citations: S 5108

- HR 4104- Health Equity and Access under the Law for Immigrant Families Act of 2025- emails to House for cosponsorship - HR 10597, S 5539- Affordability is Access Act, emails to House and Senate for cosponsorship, social media content development and engagement in support of bill re-introduction. -Letter to Senate HELP Committee opposing FDA commissioner nominee Heidi Overton

Client expense: — · Firm income: —

Matched citations: S 5539

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- met with House offices to cosponsor the bill -Meeting with Rep. Pettersen's office to discuss potential letter to EPA regarding EPA action on mifepristone - Meeting with Senator Merkley's office on potential resolution or oversight letter regarding EPA action on mifepristone - Briefing to Hill staff with asks including opposing H.R.7983 (Clean Water for All Life Act) and appropriations riders related to mifepristone environmental claims - Letter to Senate HELP Committee opposing FDA commissioner nominee Heidi Overton - Worked with Senator Murray's office on oversight letter regarding EPA action on mifepristone - HR 10597, S 5539- Affordability is Access Act, emailed House and Senate offices to get cosponsors on bill - S 5108, HR 9941- Right to IVF Act, endorsed bill - HR 10600, S 5565- Abortion is Healthcare Everywhere Act- Social media content development and engagement in support of bill re-introduction, Met with Rep. Schakowsky and Sen. Booker staff; emails to House and Senate for cosponsorship. - HR 10597, S 5539- Affordability Is Access Act- Social media content development and engagement in support of bill re-introduction, emails to House for cosponsorship

Client expense: — · Firm income: —

Matched citations: S 5539

-HR 10600, S 5565-Abortion is Healthcare Everywhere Act- Met with Rep. Schakowsky and Sen. Booker staff on bill reintroduction, reviewed text, emails to House and Senate for cosponsors, social media content development and engagement in support of bill re-introduction.

Client expense: — · Firm income: —

Matched citations: S 5565

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- met with House offices to cosponsor the bill -Meeting with Rep. Pettersen's office to discuss potential letter to EPA regarding EPA action on mifepristone - Meeting with Senator Merkley's office on potential resolution or oversight letter regarding EPA action on mifepristone - Briefing to Hill staff with asks including opposing H.R.7983 (Clean Water for All Life Act) and appropriations riders related to mifepristone environmental claims - Letter to Senate HELP Committee opposing FDA commissioner nominee Heidi Overton - Worked with Senator Murray's office on oversight letter regarding EPA action on mifepristone - HR 10597, S 5539- Affordability is Access Act, emailed House and Senate offices to get cosponsors on bill - S 5108, HR 9941- Right to IVF Act, endorsed bill - HR 10600, S 5565- Abortion is Healthcare Everywhere Act- Social media content development and engagement in support of bill re-introduction, Met with Rep. Schakowsky and Sen. Booker staff; emails to House and Senate for cosponsorship. - HR 10597, S 5539- Affordability Is Access Act- Social media content development and engagement in support of bill re-introduction, emails to House for cosponsorship

Client expense: — · Firm income: —

Matched citations: S 5565

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- urged House and Senate offices to cosponsor the bill -H.Res.1389 Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care- met with staff and drafted text -Reproductive Health Travel Fund Act (not yet introduced)- worked on drafting text -S.Res.732 / H.Res.1285 Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. Reviewed and endorsed legislation -S.4701 Freedom to Travel for Health Care Act of 2026- Reviewed and endorsed legislation - Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - S.4701 Freedom to Travel for Health Care Act of 2026- Made social media in support of bill, social media content development -S. 4922- Reproductive Health Travel Fund Act of 2026- social media content development - H.R. 9441- SAFE Training for OBGYNs Act- Endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff to discuss bill reintroduction

Client expense: $9,749 · Firm income: —

Matched citations: H.R. 4611

-Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff from Rep. Schakowsky's offices to discuss reintroduction of bill -H.R 8582/ S. 4426- Protecting Human Rights and Public Health in Foreign Assistance Act- Endorsed bill, emailed staff to cosponsor bill, social media content and development, met with colleagues to discuss advocacy strategies

Client expense: $9,749 · Firm income: —

Matched citations: H.R 8582

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- urged House and Senate offices to cosponsor the bill -H.Res.1389 Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care- met with staff and drafted text -Reproductive Health Travel Fund Act (not yet introduced)- worked on drafting text -S.Res.732 / H.Res.1285 Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. Reviewed and endorsed legislation -S.4701 Freedom to Travel for Health Care Act of 2026- Reviewed and endorsed legislation - Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - S.4701 Freedom to Travel for Health Care Act of 2026- Made social media in support of bill, social media content development -S. 4922- Reproductive Health Travel Fund Act of 2026- social media content development - H.R. 9441- SAFE Training for OBGYNs Act- Endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff to discuss bill reintroduction

Client expense: $9,749 · Firm income: —

Matched citations: H.R. 9441

- Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - S.4701 Freedom to Travel for Health Care Act of 2026- social media content development

Client expense: $9,749 · Firm income: —

Matched citations: H.R.9470

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- urged House and Senate offices to cosponsor the bill -H.Res.1389 Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care- met with staff and drafted text -Reproductive Health Travel Fund Act (not yet introduced)- worked on drafting text -S.Res.732 / H.Res.1285 Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. Reviewed and endorsed legislation -S.4701 Freedom to Travel for Health Care Act of 2026- Reviewed and endorsed legislation - Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - S.4701 Freedom to Travel for Health Care Act of 2026- Made social media in support of bill, social media content development -S. 4922- Reproductive Health Travel Fund Act of 2026- social media content development - H.R. 9441- SAFE Training for OBGYNs Act- Endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff to discuss bill reintroduction

Client expense: $9,749 · Firm income: —

Matched citations: H.R.9470

- Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - S.4701 Freedom to Travel for Health Care Act of 2026- social media content development

Client expense: $9,749 · Firm income: —

Matched citations: HR 999

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- urged House and Senate offices to cosponsor the bill -H.Res.1389 Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care- met with staff and drafted text -Reproductive Health Travel Fund Act (not yet introduced)- worked on drafting text -S.Res.732 / H.Res.1285 Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. Reviewed and endorsed legislation -S.4701 Freedom to Travel for Health Care Act of 2026- Reviewed and endorsed legislation - Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - S.4701 Freedom to Travel for Health Care Act of 2026- Made social media in support of bill, social media content development -S. 4922- Reproductive Health Travel Fund Act of 2026- social media content development - H.R. 9441- SAFE Training for OBGYNs Act- Endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff to discuss bill reintroduction

Client expense: $9,749 · Firm income: —

Matched citations: HR 999

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- urged House and Senate offices to cosponsor the bill -H.Res.1389 Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care- met with staff and drafted text -Reproductive Health Travel Fund Act (not yet introduced)- worked on drafting text -S.Res.732 / H.Res.1285 Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. Reviewed and endorsed legislation -S.4701 Freedom to Travel for Health Care Act of 2026- Reviewed and endorsed legislation - Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - S.4701 Freedom to Travel for Health Care Act of 2026- Made social media in support of bill, social media content development -S. 4922- Reproductive Health Travel Fund Act of 2026- social media content development - H.R. 9441- SAFE Training for OBGYNs Act- Endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff to discuss bill reintroduction

Client expense: $9,749 · Firm income: —

Matched citations: H.Res.1285

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- urged House and Senate offices to cosponsor the bill -H.Res.1389 Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care- met with staff and drafted text -Reproductive Health Travel Fund Act (not yet introduced)- worked on drafting text -S.Res.732 / H.Res.1285 Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. Reviewed and endorsed legislation -S.4701 Freedom to Travel for Health Care Act of 2026- Reviewed and endorsed legislation - Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - S.4701 Freedom to Travel for Health Care Act of 2026- Made social media in support of bill, social media content development -S. 4922- Reproductive Health Travel Fund Act of 2026- social media content development - H.R. 9441- SAFE Training for OBGYNs Act- Endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff to discuss bill reintroduction

Client expense: $9,749 · Firm income: —

Matched citations: H.Res.1389

-Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff from Rep. Schakowsky's offices to discuss reintroduction of bill -H.R 8582/ S. 4426- Protecting Human Rights and Public Health in Foreign Assistance Act- Endorsed bill, emailed staff to cosponsor bill, social media content and development, met with colleagues to discuss advocacy strategies

Client expense: $9,749 · Firm income: —

Matched citations: S. 4426

- Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - S.4701 Freedom to Travel for Health Care Act of 2026- social media content development

Client expense: $9,749 · Firm income: —

Matched citations: S.4701

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- urged House and Senate offices to cosponsor the bill -H.Res.1389 Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care- met with staff and drafted text -Reproductive Health Travel Fund Act (not yet introduced)- worked on drafting text -S.Res.732 / H.Res.1285 Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. Reviewed and endorsed legislation -S.4701 Freedom to Travel for Health Care Act of 2026- Reviewed and endorsed legislation - Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - S.4701 Freedom to Travel for Health Care Act of 2026- Made social media in support of bill, social media content development -S. 4922- Reproductive Health Travel Fund Act of 2026- social media content development - H.R. 9441- SAFE Training for OBGYNs Act- Endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff to discuss bill reintroduction

Client expense: $9,749 · Firm income: —

Matched citations: S.4701